down arrow

Medi Caps

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE442D01010
  • NSEID: MEDICAPS
  • BSEID: 523144
INR
43.70
-0.2 (-0.46%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 245

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Medi Caps Ltd stock-summary
stock-summary
Medi Caps Ltd
Micro Cap
Pharmaceuticals & Drugs
Medi-caps was incorporated by S L Mittal in Aug.'83 as a private limited company and was converted into a public limited company in Mar.'86. Pharmaceutical companies procure empty hard gelatine capsules from Medi-caps for dosaged medicines meant for oral administration. The company is the second-largest manufacturer of empty hard gelatine capsules in India. It takes several years for a company manufacturing capsules to attain zero-defect in production and to fully normalise operations.
Company Coordinates stock-summary
Company Details
Mhow-Neemuch Road, Sector - I Pithampur Madhya Pradesh : 454775
stock-summary
Tel: 91-07292-424242
stock-summary
investors@medicaps.com
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 12.47 Cr
Number of Shares
1.25 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
19-Mar-2013
1.25
12.47
9352467
10
Bonus
19-Mar-2013
1.25
12.47
9352467
10
Bonus
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.01%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Alok K Garg (25.87%)

Highest Public shareholder

Sangeetha S (5.57%)

Individual Investors Holdings

44.07%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
R C Mittal
Chairman (Non-Executive)
0
Alok K Garg
Managing Director
0
Pramod Fatehpuria
Non-Exec. & Independent Dir.
0
Ashok Omprakash Agrawal
Non-Exec. & Independent Dir.
0
Kusum Mittal
Non Executive Director
0
Dharmendra Solanki
Independent Director
0
Abhishek Kumar
Company Sec. & Compli. Officer
0
Gajendra Singh
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
4 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-2 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 55 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

-1.20%

stock-summary
Price to Book

0.44